| 1 |
Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH]study): a national cross-sectional study[J]. Articles, 2018, 391: 1706-1717.
|
| 2 |
潘文森，杨红申，袁雅冬，等. 慢性阻塞性肺疾病有创机械通气患者下呼吸道病原学与耐药监测[J]. 中国呼吸与危重监护杂志，2007, 6(4): 298-230.
|
| 3 |
胡振彩，赵铭山，郝 东，等. 需机械通气治疗的慢性阻塞性肺疾病急性加重期患者病原学特点及耐药性分析[J]. 潍坊医学院学报，2016, 2: 96-99.
|
| 4 |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组．慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中国医学前沿杂志电子版，2014, 6(2): 67-80.
|
| 5 |
Sethi S, Anzueto A, Miravitlles M, et al. Determinatants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease[J]. Infection, 2016, 44(1): 65-76.
|
| 6 |
Rezoagli E, Zanella A, Cressoni M, et al. Pathogenic link between post extubation pneumonia and ventilator-associated pneumonia: an experimental study[J]. Anesth Analg, 2017, 124(4): 1339-1346.
|
| 7 |
Patil HV, Virendra C. Incidence, bacteriology, and clinical outcome of ventilator-associated pneumonia at tertiary care hospital[J]. Patil J Nat Sci Biol Med, 2017, 8(1): 46-55.
|
| 8 |
Zhang J, Zheng J, Huang K, et al. Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study[J]. Ther Adv Respir Dis, 2018, 12: 1-7.
|
| 9 |
Antonucci E, Fiaccadori E, Taccone FS, et al. Glucocorticoid administration in sepsis and septic shock: time for a paradigm change? [J]. Minerva Anestesiol, 2014, 80(9): 1059-1062.
|
| 10 |
Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals：Multidrug-resistant Acinetbacter baumannii[J]. Nat Rev Microbiol, 2007, 5(12): 939-951.
|
| 11 |
Morgan DJ, Liang SY, Smith CL, et al. Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers[J]. Infect Ctrl Hosp Epidemiol, 2010, 31(7): 716-721.
|
| 12 |
Hassett DJ, Borchers MT, Panos RJ. Chronic obstructive pulmonary disease (COPD): evaluation from clinical immunological and bacterial pathogenesis perspectives[J]. J Microbiol, 2014, 52(3): 211-226.
|
| 13 |
陈代杰，郭蓓宁，杨信怡，等. 鲍曼不动耐药机制[J]．中国感染与化疗杂志，2015, 15(3): 286-288.
|
| 14 |
Domenech A, Puig C, Martí S, et al. Infectious etiology of acute exacerbations in severe COPD patients[J]. J Infect, 2013, 67(6): 516-523.
|
| 15 |
高春波，苏丽菊，韩 笑，等. 铜绿假单胞菌和鲍曼不动杆菌感染分布特征及耐药性分析[J]. 国际检验医学杂志，2016, 37(19): 2682-2684.
|
| 16 |
Paramewaran GI, Sethi S. Pseudomonas infection in chronic obstructive pulmonary disease[J]. Future Microbiol, 2012, 7(10): 1129-1132.
|
| 17 |
史 燕，方 英，李云娜，等. 慢性阻塞性肺疾病合并肺部真菌感染的危险因素分析及护理对策[J]. 中华全科医学，2018, 16(2): 309-312.
|
| 18 |
汪 群，张 蔷，黄 静，等. 急性期慢性阻塞性肺疾病真菌感染高危因素分析及疗效观察[J]. 中国真菌学杂志，2018, 13(1): 15-19.
|
| 19 |
Su J, Liu HY, Tan XL, et al. Sputum bacterial and fungal dynamics during exacerbations of severe COPD[J]. PLoS ONE, 2015, 10(7): e0130736.
|
| 20 |
李艳肖，史金英，柴书坤. 等. 慢性阻塞性肺疾病合并真菌感染危险因素及病原学分析[J]. 河北医药，2013, 9: 1402-1403.
|